Context Therapeutics Inc. Common Stock (CNTX)

Stock · NASDAQ · Health Care

$0.3836as of 8/28/2026

Price chart

Insider transactionsShow all transaction typesRevenue Growth

High Beta36.2%

Resistance level

$0.567969

Industry

Biotechnology: Pharmaceutical Preparations

Chosen by industry and closest market cap.

CNTX
Context Therapeutics Inc. Common Stock
$0.3836
▼ 7.79%
Market cap $46.31MP/E —
MREO
Mereo BioPharma Group plc American Depositary Shares
$0.2545
▼ 6.43%
Market cap $47.46MP/E —
$0.2$2.37
KPTI
Karyopharm Therapeutics Inc. Common Stock
$1.88
▼ 3.09%
Market cap $44.19MP/E —
$1.79$10.99
TCRT
Alaunos Therapeutics Inc. Common Stock
$1.56
▼ 6.02%
Market cap $48.60MP/E —
$1.62$4.59
IBO
Impact BioMedical Inc. Common Stock
$0.444
▲ 0.68%
Market cap $48.61MP/E 0.52
$0.37$0.83
PDSB
PDS Biotechnology Corporation Common Stock
$0.211
▼ 3.21%
Market cap $41.78MP/E —
SCYX
SCYNEXIS Inc. Common Stock
$5.44
▼ 1.45%
Market cap $51.64MP/E —
$3.53$10.48

Symbol	Market cap	P/E ratio	Price	1D	52-week range
CNTX Context Therapeutics Inc. Common Stock	$46.31M	—	$0.3836	▼ 7.79%
MREO Mereo BioPharma Group plc American Depositary Shares	$47.46M	—	$0.2545	▼ 6.43%	$0.2$2.37
KPTI Karyopharm Therapeutics Inc. Common Stock	$44.19M	—	$1.88	▼ 3.09%	$1.79$10.99
TCRT Alaunos Therapeutics Inc. Common Stock	$48.60M	—	$1.56	▼ 6.02%	$1.62$4.59
IBO Impact BioMedical Inc. Common Stock	$48.61M	0.52	$0.444	▲ 0.68%	$0.37$0.83
PDSB PDS Biotechnology Corporation Common Stock	$41.78M	—	$0.211	▼ 3.21%
SCYX SCYNEXIS Inc. Common Stock	$51.64M	—	$5.44	▼ 1.45%	$3.53$10.48

P/E shows — for peers not currently carrying a live signal of their own.

March 31, 2026

Top holders this quarter

See the full, filterable feed with live charts on the MarketWall dashboard.